These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26674479)

  • 1. Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review.
    Sher Y; Miller Cramer AC; Ament A; Lolak S; Maldonado JR
    Psychosomatics; 2015; 56(6):615-25. PubMed ID: 26674479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged Refractory ICU Delirium Successfully Treated With Valproic Acid: Case Report and Literature Review.
    Subedi B; Louzon PR; Masood A; Recksieck S
    J Pharm Pract; 2021 Dec; 34(6):984-987. PubMed ID: 32912027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Valproic Acid for the Management of Delirium and Agitation in the Intensive Care Unit.
    Swayngim R; Preslaski C; Dawson J
    J Pharm Pract; 2024 Feb; 37(1):118-122. PubMed ID: 36154329
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproic Acid in the Management of Delirium.
    Cuartas CF; Davis M
    Am J Hosp Palliat Care; 2022 May; 39(5):562-569. PubMed ID: 34409869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale.
    Sher Y; Miller AC; Lolak S; Ament A; Maldonado JR
    J Neuropsychiatry Clin Neurosci; 2015; 27(4):365-70. PubMed ID: 25803136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic Acid for the Management of Agitation and Delirium in the Intensive Care Setting: A Retrospective Analysis.
    Crowley KE; Urben L; Hacobian G; Geiger KL
    Clin Ther; 2020 Apr; 42(4):e65-e73. PubMed ID: 32273047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing Practices of Valproic Acid for Agitation and Delirium in the Intensive Care Unit.
    Quinn NJ; Hohlfelder B; Wanek MR; Duggal A; Torbic H
    Ann Pharmacother; 2021 Mar; 55(3):311-317. PubMed ID: 32748626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive valproic acid for delirium and/or agitation on a consultation-liaison service: a report of six cases.
    Bourgeois JA; Koike AK; Simmons JE; Telles S; Eggleston C
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):232-8. PubMed ID: 15939979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Agents for the Management of Agitation and Agitated Delirium in Critically Ill Patients.
    Yeo QM; Wiley TL; Smith MN; Hammond DA
    Crit Care Nurs Q; 2017; 40(4):344-362. PubMed ID: 28834857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficacy of antipsychotics in treatment of delirium and agitation in two cases of bickerstaff brainstem encephalitis.
    Alam A; Puri NV
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):176-8. PubMed ID: 24763765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults.
    White G; Adessky N; Chen FW; Regazzoni A; Tourian L; Chagnon M; Gursahaney A; Alharbi M; Williamson D; Perreault MM
    Int J Clin Pharm; 2024 Feb; 46(1):177-185. PubMed ID: 38071694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
    Yoshimura R; Shinkai K; Ueda N; Nakamura J
    Pharmacopsychiatry; 2007 Jan; 40(1):9-13. PubMed ID: 17327954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine is a reasonable alternative to haloperidol in the treatment of postoperative hyperactive-type delirium after cardiac surgery.
    Atalan N; Efe Sevim M; Akgün S; Fazlıoğulları O; Başaran C
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):933-8. PubMed ID: 23791495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain, agitation, delirium, and neuromuscular blockade: a review of basic pharmacology, assessment, and monitoring.
    Altshuler J; Spoelhof B
    Crit Care Nurs Q; 2013; 36(4):356-69. PubMed ID: 24002426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.
    Mahmoud F; Tampi RR
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):405-12. PubMed ID: 21993183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Valproate induced hypoactive delirium in a bipolar disorder patient with psychotic features].
    Ozen S; Bülbül I; Soyuçok E
    Turk Psikiyatri Derg; 2010; 21(1):79-84. PubMed ID: 20204907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid as anti-cancer drug.
    Michaelis M; Doerr HW; Cinatl J
    Curr Pharm Des; 2007; 13(33):3378-93. PubMed ID: 18045192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agitated symptom response to divalproex following acute brain injury.
    Chatham Showalter PE; Kimmel DN
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):395-7. PubMed ID: 10956575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.